152 related articles for article (PubMed ID: 9050770)
1. Effects of low-dose pravastatin sodium on plasma cholesterol levels and aortic atherosclerosis of heterozygous WHHL rabbits fed a low cholesterol (0.03%) enriched diet for one year.
Harsch M; Braesen JH; Niendorf A
Atherosclerosis; 1997 Feb; 128(2):139-47. PubMed ID: 9050770
[TBL] [Abstract][Full Text] [Related]
2. Survival and cardiovascular pathology of heterozygous Watanabe heritable hyperlipidaemic rabbits treated with pravastatin and probucol on a low-cholesterol (0.03%)-enriched diet.
Bräsen JH; Harsch M; Niendorf A
Virchows Arch; 1998 Jun; 432(6):557-62. PubMed ID: 9672198
[TBL] [Abstract][Full Text] [Related]
3. Pravastatin decreases serum lipids and vascular cholesterol deposition in Watanabe heritable hyperlipidemic (WHHL) rabbits.
Khachadurian AK; Shimamura T; Rozovski SJ; Ananthakrishnan R; Armenian B; Coly E; alHinai A; Martucci C; Schneider SH; Amorosa LF
Jpn Heart J; 1991 Sep; 32(5):675-85. PubMed ID: 1774829
[TBL] [Abstract][Full Text] [Related]
4. Effects of pravastatin on cholesterol metabolism of cholesterol-fed heterozygous WHHL rabbits.
Harsch M; Gebhardt A; Reymann A; Lang G; Schliack M; Löser R; Braesen JH; Niendorf A
Br J Pharmacol; 1998 May; 124(2):277-82. PubMed ID: 9641543
[TBL] [Abstract][Full Text] [Related]
5. Reduction of serum cholesterol levels alters lesional composition of atherosclerotic plaques. Effect of pravastatin sodium on atherosclerosis in mature WHHL rabbits.
Shiomi M; Ito T; Tsukada T; Yata T; Watanabe Y; Tsujita Y; Fukami M; Fukushige J; Hosokawa T; Tamura A
Arterioscler Thromb Vasc Biol; 1995 Nov; 15(11):1938-44. PubMed ID: 7583574
[TBL] [Abstract][Full Text] [Related]
6. Cholesterol-fed heterozygous Watanabe heritable hyperlipidemic rabbits: a new model for atherosclerosis.
Atkinson JB; Hoover RL; Berry KK; Swift LL
Atherosclerosis; 1989 Aug; 78(2-3):123-36. PubMed ID: 2783197
[TBL] [Abstract][Full Text] [Related]
7. The effect of cholesterol reduction on the endothelial function and progression of atherosclerosis in WHHL rabbits.
Kroon AA; Stalenhoef AF; Buikema H; Demacker PN; de Wilde PC; Leijten PA; van Gilst WH
Atherosclerosis; 1993 Nov; 103(2):221-30. PubMed ID: 8292097
[TBL] [Abstract][Full Text] [Related]
8. Effect of FR145237, a novel ACAT inhibitor, on atherogenesis in cholesterol-fed and WHHL rabbits. Evidence for a direct effect on the arterial wall.
Matsuo M; Ito F; Konto A; Aketa M; Tomoi M; Shimomura K
Biochim Biophys Acta; 1995 Dec; 1259(3):254-60. PubMed ID: 8541332
[TBL] [Abstract][Full Text] [Related]
9. Fibromuscular cap composition is important for the stability of established atherosclerotic plaques in mature WHHL rabbits treated with statins.
Shiomi M; Ito T; Hirouchi Y; Enomoto M
Atherosclerosis; 2001 Jul; 157(1):75-84. PubMed ID: 11427206
[TBL] [Abstract][Full Text] [Related]
10. Pravastatin sodium, a competitive inhibitor of hepatic 3-hydroxy-3-methylglutaryl coenzyme A reductase, decreases the cholesterol content of newly secreted very-low-density lipoprotein in Watanabe heritable hyperlipidemic rabbits.
Shiomi M; Ito T
Metabolism; 1994 May; 43(5):559-64. PubMed ID: 8177044
[TBL] [Abstract][Full Text] [Related]
11. Combination therapy with cilostazol and pravastatin improves antiatherogenic effects in low-density lipoprotein receptor knockout mice.
Park KY; Heo TH
Cardiovasc Ther; 2018 Dec; 36(6):e12476. PubMed ID: 30378752
[TBL] [Abstract][Full Text] [Related]
12. Combination treatment with troglitazone, an insulin action enhancer, and pravastatin, an inhibitor of HMG-CoA reductase, shows a synergistic effect on atherosclerosis of WHHL rabbits.
Shiomi M; Ito T; Tsukada T; Tsujita Y; Horikoshi H
Atherosclerosis; 1999 Feb; 142(2):345-53. PubMed ID: 10030386
[TBL] [Abstract][Full Text] [Related]
13. Nifedipine reduces atherogenesis in cholesterol-fed heterozygous WHHL rabbits.
Atkinson JB; Swift LL
Atherosclerosis; 1990 Oct; 84(2-3):195-201. PubMed ID: 2282099
[TBL] [Abstract][Full Text] [Related]
14. Low-dose cerivastatin inhibits spontaneous atherogenesis in heterozygous watanabe hyper lipidemic rabbits.
Pauletto P; Puato M; Faggin E; Sartore S
J Vasc Res; 2000; 37(3):189-94. PubMed ID: 10859477
[TBL] [Abstract][Full Text] [Related]
15. Augmented vasoconstrictor responses to serotonin precede development of atherosclerosis in aorta of WHHL rabbit.
Wines PA; Schmitz JM; Pfister SL; Clubb FJ; Buja LM; Willerson JT; Campbell WB
Arteriosclerosis; 1989; 9(2):195-202. PubMed ID: 2647071
[TBL] [Abstract][Full Text] [Related]
16. Preventive effect of pravastatin sodium, a potent inhibitor of 3-hydroxy-3-methylglutaryl coenzyme A reductase, on coronary atherosclerosis and xanthoma in WHHL rabbits.
Watanabe Y; Ito T; Shiomi M; Tsujita Y; Kuroda M; Arai M; Fukami M; Tamura A
Biochim Biophys Acta; 1988 Jun; 960(3):294-302. PubMed ID: 3132979
[TBL] [Abstract][Full Text] [Related]
17. Effect of cerivastatin sodium, a new inhibitor of HMG-CoA reductase, on plasma lipid levels, progression of atherosclerosis, and the lesional composition in the plaques of WHHL rabbits.
Shiomi M; Ito T
Br J Pharmacol; 1999 Feb; 126(4):961-8. PubMed ID: 10193776
[TBL] [Abstract][Full Text] [Related]
18. Suppression of established atherosclerosis and xanthomas in mature WHHL rabbits by keeping their serum cholesterol levels extremely low. Effect of pravastatin sodium in combination with cholestyramine.
Shiomi M; Ito T; Watanabe Y; Tsujita Y; Kuroda M; Arai M; Fukami M; Fukushige J; Tamura A
Atherosclerosis; 1990 Jul; 83(1):69-80. PubMed ID: 2117930
[TBL] [Abstract][Full Text] [Related]
19. Effects of atherosclerotic plaque on the enlargement of an experimental model of abdominal aortic aneurysm in rabbits.
Kobayashi H; Matsushita M; Oda K; Nishikimi N; Sakurai T; Komori K
Eur J Vasc Endovasc Surg; 2004 Jul; 28(1):71-8. PubMed ID: 15177235
[TBL] [Abstract][Full Text] [Related]
20. Anti-atherosclerotic effect of E5324, an inhibitor of acyl-CoA:cholesterol acyltransferase, in Watanabe heritable hyperlipidemic rabbits.
Kogushi M; Tanaka H; Ohtsuka I; Yamada T; Kobayashi H; Saeki T; Takada M; Hiyoshi H; Yanagimachi M; Kimura T; Yoshitake S; Saito I
Atherosclerosis; 1996 Aug; 124(2):203-10. PubMed ID: 8830933
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
